Global Quadrivalent Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 90
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Quadrivalent Flu Vaccine market size was valued at USD 5437.8 million in 2023 and is forecast to a readjusted size of USD 7836.6 million by 2030 with a CAGR of 5.4% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Quadrivalent Flu Vaccine industry chain, the market status of Hospital (Intramuscular Injection, Nasal Spray), Clinic (Intramuscular Injection, Nasal Spray), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Quadrivalent Flu Vaccine.
Regionally, the report analyzes the Quadrivalent Flu Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Quadrivalent Flu Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Quadrivalent Flu Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Quadrivalent Flu Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Intramuscular Injection, Nasal Spray).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Quadrivalent Flu Vaccine market.
Regional Analysis: The report involves examining the Quadrivalent Flu Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Quadrivalent Flu Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Quadrivalent Flu Vaccine:
Company Analysis: Report covers individual Quadrivalent Flu Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Quadrivalent Flu Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Quadrivalent Flu Vaccine. It assesses the current state, advancements, and potential future developments in Quadrivalent Flu Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Quadrivalent Flu Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Quadrivalent Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Intramuscular Injection
Nasal Spray
Intradermal Shot
Market segment by Application
Hospital
Clinic
Public Health Agency
Other
Major players covered
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Quadrivalent Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Quadrivalent Flu Vaccine, with price, sales, revenue and global market share of Quadrivalent Flu Vaccine from 2019 to 2024.
Chapter 3, the Quadrivalent Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Quadrivalent Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Quadrivalent Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Quadrivalent Flu Vaccine.
Chapter 14 and 15, to describe Quadrivalent Flu Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Quadrivalent Flu Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Quadrivalent Flu Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Intramuscular Injection
1.3.3 Nasal Spray
1.3.4 Intradermal Shot
1.4 Market Analysis by Application
1.4.1 Overview: Global Quadrivalent Flu Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Public Health Agency
1.4.5 Other
1.5 Global Quadrivalent Flu Vaccine Market Size & Forecast
1.5.1 Global Quadrivalent Flu Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Quadrivalent Flu Vaccine Sales Quantity (2019-2030)
1.5.3 Global Quadrivalent Flu Vaccine Average Price (2019-2030)
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Product and Services
2.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Quadrivalent Flu Vaccine Product and Services
2.2.4 AstraZeneca Quadrivalent Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Quadrivalent Flu Vaccine Product and Services
2.3.4 CSL Quadrivalent Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CSL Recent Developments/Updates
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Quadrivalent Flu Vaccine Product and Services
2.4.4 Abbott Quadrivalent Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Abbott Recent Developments/Updates
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Product and Services
2.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline Recent Developments/Updates
3.1 Global Quadrivalent Flu Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Quadrivalent Flu Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Quadrivalent Flu Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Quadrivalent Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Quadrivalent Flu Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Quadrivalent Flu Vaccine Manufacturer Market Share in 2023
3.5 Quadrivalent Flu Vaccine Market: Overall Company Footprint Analysis
3.5.1 Quadrivalent Flu Vaccine Market: Region Footprint
3.5.2 Quadrivalent Flu Vaccine Market: Company Product Type Footprint
3.5.3 Quadrivalent Flu Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Quadrivalent Flu Vaccine Market Size by Region
4.1.1 Global Quadrivalent Flu Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Quadrivalent Flu Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Quadrivalent Flu Vaccine Average Price by Region (2019-2030)
4.2 North America Quadrivalent Flu Vaccine Consumption Value (2019-2030)
4.3 Europe Quadrivalent Flu Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Quadrivalent Flu Vaccine Consumption Value (2019-2030)
4.5 South America Quadrivalent Flu Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Quadrivalent Flu Vaccine Consumption Value (2019-2030)
5.1 Global Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Quadrivalent Flu Vaccine Consumption Value by Type (2019-2030)
5.3 Global Quadrivalent Flu Vaccine Average Price by Type (2019-2030)
6.1 Global Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Quadrivalent Flu Vaccine Consumption Value by Application (2019-2030)
6.3 Global Quadrivalent Flu Vaccine Average Price by Application (2019-2030)
7.1 North America Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Quadrivalent Flu Vaccine Market Size by Country
7.3.1 North America Quadrivalent Flu Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Quadrivalent Flu Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Quadrivalent Flu Vaccine Market Size by Country
8.3.1 Europe Quadrivalent Flu Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Quadrivalent Flu Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Quadrivalent Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Quadrivalent Flu Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Quadrivalent Flu Vaccine Market Size by Country
10.3.1 South America Quadrivalent Flu Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Quadrivalent Flu Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Quadrivalent Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Quadrivalent Flu Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Quadrivalent Flu Vaccine Market Drivers
12.2 Quadrivalent Flu Vaccine Market Restraints
12.3 Quadrivalent Flu Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Quadrivalent Flu Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Quadrivalent Flu Vaccine
13.3 Quadrivalent Flu Vaccine Production Process
13.4 Quadrivalent Flu Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Quadrivalent Flu Vaccine Typical Distributors
14.3 Quadrivalent Flu Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Quadrivalent Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Quadrivalent Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Quadrivalent Flu Vaccine Product and Services
Table 6. Sanofi Pasteur Quadrivalent Flu Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca Quadrivalent Flu Vaccine Product and Services
Table 11. AstraZeneca Quadrivalent Flu Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. CSL Basic Information, Manufacturing Base and Competitors
Table 14. CSL Major Business
Table 15. CSL Quadrivalent Flu Vaccine Product and Services
Table 16. CSL Quadrivalent Flu Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. CSL Recent Developments/Updates
Table 18. Abbott Basic Information, Manufacturing Base and Competitors
Table 19. Abbott Major Business
Table 20. Abbott Quadrivalent Flu Vaccine Product and Services
Table 21. Abbott Quadrivalent Flu Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Abbott Recent Developments/Updates
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Quadrivalent Flu Vaccine Product and Services
Table 26. GlaxoSmithKline Quadrivalent Flu Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. GlaxoSmithKline Recent Developments/Updates
Table 28. Global Quadrivalent Flu Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 29. Global Quadrivalent Flu Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 30. Global Quadrivalent Flu Vaccine Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 31. Market Position of Manufacturers in Quadrivalent Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 32. Head Office and Quadrivalent Flu Vaccine Production Site of Key Manufacturer
Table 33. Quadrivalent Flu Vaccine Market: Company Product Type Footprint
Table 34. Quadrivalent Flu Vaccine Market: Company Product Application Footprint
Table 35. Quadrivalent Flu Vaccine New Market Entrants and Barriers to Market Entry
Table 36. Quadrivalent Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Quadrivalent Flu Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 38. Global Quadrivalent Flu Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 39. Global Quadrivalent Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 40. Global Quadrivalent Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 41. Global Quadrivalent Flu Vaccine Average Price by Region (2019-2024) & (USD/Dose)
Table 42. Global Quadrivalent Flu Vaccine Average Price by Region (2025-2030) & (USD/Dose)
Table 43. Global Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 44. Global Quadrivalent Flu Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 45. Global Quadrivalent Flu Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 46. Global Quadrivalent Flu Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 47. Global Quadrivalent Flu Vaccine Average Price by Type (2019-2024) & (USD/Dose)
Table 48. Global Quadrivalent Flu Vaccine Average Price by Type (2025-2030) & (USD/Dose)
Table 49. Global Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 50. Global Quadrivalent Flu Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 51. Global Quadrivalent Flu Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 52. Global Quadrivalent Flu Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 53. Global Quadrivalent Flu Vaccine Average Price by Application (2019-2024) & (USD/Dose)
Table 54. Global Quadrivalent Flu Vaccine Average Price by Application (2025-2030) & (USD/Dose)
Table 55. North America Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 56. North America Quadrivalent Flu Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 57. North America Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 58. North America Quadrivalent Flu Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 59. North America Quadrivalent Flu Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 60. North America Quadrivalent Flu Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 61. North America Quadrivalent Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 62. North America Quadrivalent Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 63. Europe Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 64. Europe Quadrivalent Flu Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 65. Europe Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 66. Europe Quadrivalent Flu Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 67. Europe Quadrivalent Flu Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 68. Europe Quadrivalent Flu Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 69. Europe Quadrivalent Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Quadrivalent Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 72. Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 73. Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 74. Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 75. Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 76. Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 77. Asia-Pacific Quadrivalent Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 78. Asia-Pacific Quadrivalent Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 79. South America Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 80. South America Quadrivalent Flu Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 81. South America Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 82. South America Quadrivalent Flu Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 83. South America Quadrivalent Flu Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 84. South America Quadrivalent Flu Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 85. South America Quadrivalent Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 86. South America Quadrivalent Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 87. Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 88. Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 89. Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
Table 90. Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
Table 91. Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 92. Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 93. Middle East & Africa Quadrivalent Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 94. Middle East & Africa Quadrivalent Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 95. Quadrivalent Flu Vaccine Raw Material
Table 96. Key Manufacturers of Quadrivalent Flu Vaccine Raw Materials
Table 97. Quadrivalent Flu Vaccine Typical Distributors
Table 98. Quadrivalent Flu Vaccine Typical Customers
List of Figures
Figure 1. Quadrivalent Flu Vaccine Picture
Figure 2. Global Quadrivalent Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Quadrivalent Flu Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Intramuscular Injection Examples
Figure 5. Nasal Spray Examples
Figure 6. Intradermal Shot Examples
Figure 7. Global Quadrivalent Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Quadrivalent Flu Vaccine Consumption Value Market Share by Application in 2023
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Public Health Agency Examples
Figure 12. Other Examples
Figure 13. Global Quadrivalent Flu Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Quadrivalent Flu Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Quadrivalent Flu Vaccine Sales Quantity (2019-2030) & (K Doses)
Figure 16. Global Quadrivalent Flu Vaccine Average Price (2019-2030) & (USD/Dose)
Figure 17. Global Quadrivalent Flu Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Quadrivalent Flu Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Quadrivalent Flu Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Quadrivalent Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Quadrivalent Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Quadrivalent Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Quadrivalent Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Quadrivalent Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Quadrivalent Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Quadrivalent Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Quadrivalent Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Quadrivalent Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Quadrivalent Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Quadrivalent Flu Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Quadrivalent Flu Vaccine Average Price by Type (2019-2030) & (USD/Dose)
Figure 32. Global Quadrivalent Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Quadrivalent Flu Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Quadrivalent Flu Vaccine Average Price by Application (2019-2030) & (USD/Dose)
Figure 35. North America Quadrivalent Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Quadrivalent Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Quadrivalent Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Quadrivalent Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Quadrivalent Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Quadrivalent Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Quadrivalent Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Quadrivalent Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Quadrivalent Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 55. China Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Quadrivalent Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Quadrivalent Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Quadrivalent Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Quadrivalent Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Quadrivalent Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Quadrivalent Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Quadrivalent Flu Vaccine Market Drivers
Figure 76. Quadrivalent Flu Vaccine Market Restraints
Figure 77. Quadrivalent Flu Vaccine Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Quadrivalent Flu Vaccine in 2023
Figure 80. Manufacturing Process Analysis of Quadrivalent Flu Vaccine
Figure 81. Quadrivalent Flu Vaccine Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sanofi Pasteur AstraZeneca CSL Abbott GlaxoSmithKline
Related Reports
17 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
